Notify me when V-CO Investors LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VVOS | Vivos Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 20% | $4,188,594 | +$2,583,360 | 1,342,498 | +161% | SP Manager LLC | 09 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|